[ad_1] The U.S. should pursue a COVID-19 booster strategy that focuses on developing new shots…
science
-
-
STOCK MARKET
CEO who wants his company to be the Toyota of rocket launchers says losing two-thirds of its value won’t change strategy
by userby user[ad_1] It’s never easy for an executive to witness losing two-thirds of his company’s value…
-
STOCK MARKET
Elon Musk’s autonomous vehicle forecasts are not just too optimistic — they’re wrong
by userby user[ad_1] Autonomy is supposed to make rides in Tesla’s TSLA, -0.05% planned robotaxis affordable and…
-
[ad_1] The majority of people in the U.S. who are testing positive for the coronavirus…
-
[ad_1] Biogen Inc.’s BIIB, +1.23% decision to let go of its CEO and scrap commercial…
-
STOCK MARKET
The power plants of the future will be solar and battery hybrids — and it’s already starting
by userby user[ad_1] America’s electric power system is undergoing radical change as it transitions from fossil fuels…
-
STOCK MARKET
Lilly’s experimental weight-loss drug may be a ‘multibillion-dollar opportunity’
by userby user[ad_1] Eli Lilly & Co. Inc.’s LLY, -1.46% promising new weight-loss drug is taking aim…
-
STOCK MARKET
How Gilead is positioning Veklury against COVID-19 antivirals like Paxlovid
by userby user[ad_1] Gilead Sciences Inc. GILD, -0.29% has steadily expanded the use of Veklury while much…
-
STOCK MARKET
Can a decades-old antidepressant keep COVID-19 patients out of the hospital?
by userby user[ad_1] A generic antidepressant may be able to keep COVID-19 patients out of the hospital,…
-
STOCK MARKET
As Washington gets closer to delivering an innovation and competition package, online marketplaces are battling with manufacturers over provisions aimed at fake products
by userby user[ad_1] Both the House and Senate are getting back to work in Washington next week,…